Douglas J. Zeckner

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

John D. Carpten, Andrew L. Faber, Candice L. Horn et al. · Nature · 2007 · 1.3K citations

Somatic Variant, Medicine, Pleckstrin Homology Domain +6

Semisynthetic Chemical Modification of the Antifungal Lipopeptide Echinocandin B (ECB): Structure-Activity Studies of the Lipophilic and Geometric Parameters of Polyarylated Acyl Analogs of ECB

Manuel Debono, William W. Turner, Lisa LaGrandeur et al. · Journal of Medicinal Chemistry · 1995 · 112 citations

Semisynthetic Chemical Modification, Geometric Parameters, Chemical Biology +16

In vitro and in vivo anti-Candida activity and toxicology of LY121019.

Robert S. Gordee, Douglas J. Zeckner, L. F. Ellis et al. · The Journal of Antibiotics · 1984 · 109 citations · Full text

A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models

Tinggui Yin, Marı́a José Lallena, Emiko L. Kreklau et al. · Molecular Cancer Therapeutics · 2014 · 101 citations · Full text

Tumor Biology, Medicine, Malignant Blood Disorder +14

Characterization of LY3023414, a Novel PI3K/mTOR Dual Inhibitor Eliciting Transient Target Modulation to Impede Tumor Growth

Michèle C. Smith, Mary M. Mader, James A. Cook et al. · Molecular Cancer Therapeutics · 2016 · 74 citations